Percutaneous administration of allogeneic bone-forming cells for the treatment of delayed unions of fractures: a pilot study

202118 citationsJournal Articlegold Open Access

Authors

Marc Jayankura · Erasmus Hospital

Arndt‐Peter Schulz · BG Klinikum Hamburg

Olivier Delahaut · Grand Charleroi Hospital

Richard Witvrouw · Ziekenhuis Oost-Limburg

Lothar Seefried · University of Würzburg

Bruno Berg · Cliniques Universitaires Saint-Luc

G Heynen ·

Abstract

NCT02020590 . Registered on 25 December 2013. ALLOB-DU1, A pilot Phase I/IIa, multicentre, open proof-of-concept study on the efficacy and safetyof allogeneic osteoblastic cells (ALLOB®) implantation in non-infected delayed-union fractures.

Topics & Keywords

Bone fractures and treatments Mesenchymal stem cell research Hip and Femur Fractures

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Stem Cell Research & Therapy

Volume 12, Issue 1, pp. 363-363

DOI: 10.1186/s13287-021-02432-4

Field-Weighted Citation Impact: 1.21